of companies (the “Project”) which aims to clearly separate the business line within OISHI’s group of companies, enhance the management and administration flexibility and increase the capability of the
results for the 3-month period ending 31 March 2020 and 2019 (Unit: Thousand Baht) Consolidated Financial Statements Increase (Decrease) Separate Financial Statements Increase (Decrease) 2020 2019 Thousand
Analysis of Operating Results for the Company and its subsidiary Table 1: Overall Annual Operating Results for the year of 2018 and 2017 (Unit : Thousand Baht) Consolidated Financial Statements Separate
Separate Financial Statements Increase (Decrease) % 2018 2018 2017 Total revenues 1,626,468 1,544,670 1,644,433 (17,965) (1.1) Sales and service income 1,614,607 1,531,983 1,637,162 (22,555) (1.4) Cost of
: Overall operating results for the three-month period ended March 31, 2019 and 2018 (Unit: Thousand Baht) Consolidated Financial Statements Separate Financial Statements Increase (Decrease) Q1/2019 Q1/2019
Medical Business Plc., (CMR) amount Baht 1,010.31 million. comparing at the same period in 2017 representing 18.19% increase. Income from medical treatments in the separate financial went up 17.07% due to
Chiang Mai Ram Medical Business Plc., (CMR) amount Baht 995.22 million comparing at the same period in 2018 representing 1.86% increase . Income from medical treatments in the separate financial went up
ended September 30, 2019 To The President and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the reviewed consolidated and separate
Medical Business Plc., (CMR) amount Baht 854.83 million. comparing at the same period in 2016 representing 3.30% increase. Income from medical treatments in the separate financial went down 3.46% due to the